AtriCure price to free cash flow ATRC
Market value divided by free cash flow over the last twelve months, since 2025.
- Today, Nov 2, 2026
- 57.3×
- Peer median
- 24.8×
AtriCure's price to free cash flow is 57.3× as of Nov 2, 2026.
The median for 10 medical instruments and supplies stocks of a similar size is 24.8×.
Price to free cash flow over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 57.3× | 24.8× | 62.5× |
| 2025 | 60.8× | 48.3× | 153× |
Against its peers
Companies in Medical - Instruments & Supplies nearest AtriCure's size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| ATRCAtriCure | 57.3× |
| WRBYWarby Parker | 136× |
| NVSTEnvista | 16.0× |
| ICUIICU Medical | 26.6× |
| UFPTUFP Technologies | n/m |
| BMIBadger Meter | 31.6× |
| INSPInspire Medical Systems | 16.6× |
| VNTVontier | 12.9× |
| LMATLemaitre Vascular | 25.2× |
| MMSIMerit Medical Systems | 24.8× |
| HAEHaemonetics | 18.8× |
| Peer median | 24.8× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on AtriCure
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.